Stay updated on Psilocybin for Alcohol Use Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Alcohol Use Disorder Clinical Trial page.

Latest updates to the Psilocybin for Alcohol Use Disorder Clinical Trial page
- Check4 days agoChange DetectedThe record now presents details of a Phase 2 feasibility study investigating single-dose psilocybin for alcohol use disorder, including eligibility, study procedures, outcomes, and investigators.SummaryDifference55%

- Check11 days agoChange DetectedThe ClinicalTrials.gov site footer now shows revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide notice announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study record view. The site header and footer remain visible, but access to the study content is blocked.SummaryDifference0.5%

Stay in the know with updates to Psilocybin for Alcohol Use Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Alcohol Use Disorder Clinical Trial page.